FDG-PET/CT Imaging Predicts Histopathologic Treatment Responses after Neoadjuvant Therapy in Adult Primary Bone Sarcomas

Figure 4

FDG-PET/CT at baseline, early followup, and after completion of neoadjuvant treatments in a histopathological responder (a) and a nonresponder (b).

(a)

(b)